The global market for endoscopic retrograde cholangiopancreatography (ERCP) devices is set to experience significant growth over the next decade, with estimates predicting sales to increase from USD 1,628.6 million in 2024 to an impressive USD 3,000.2 million by 2034. This remarkable growth translates to a compound annual growth rate (CAGR) of 6.3% during the forecast …
Tag Archives: Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market
Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market to Surge, Reaching USD 2.8 Billion by 2032
The global endoscopic retrograde cholangiopancreatography (ERCP) devices market is poised for significant growth, with projections indicating a rise to USD 2.8 billion by 2032, up from USD 1.5 billion in 2022. This surge is attributed to the escalating incidence of cancer worldwide, as highlighted by industry insights from Future Market Insights (FMI). ERCP, a vital …
Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Targets US$ 2.8 Billion Milestone by 2032
The endoscopic retrograde cholangiopancreatography (ERCP) devices market sales is expected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032 as a result of an increase in cancer incidence worldwide. The market for endoscopic retrograde cholangiopancreatography (ERCP) equipment is anticipated to develop at a compound annual growth rate (CAGR) of 6.2% between 2022 and …
Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Aims for a US$ 2.8 Billion Milestone by 2032-FMI Projection
The endoscopic retrograde cholangiopancreatography (ERCP) devices market sales is expected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032 as a result of an increase in cancer incidence worldwide. The market for endoscopic retrograde cholangiopancreatography (ERCP) equipment is anticipated to develop at a compound annual growth rate (CAGR) of 6.2% between …
Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Eyes US$ 2.8 Billion Milestone by 2032-FMI Study
The endoscopic retrograde cholangiopancreatography (ERCP) devices market is expected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032 as a result of an increase in cancer incidence worldwide. FMI projects that between 2022 and 2032, the market for endoscopic retrograde cholangiopancreatography (ERCP) devices will expand at a compound annual growth rate …
Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Set to Reach US$ 2.8 Billion by 2032 | Future market Insights,Inc.
Due to an increase in cancer cases worldwide, the endoscopic retrograde cholangiopancreatography (ERCP) devices market is projected to reach US$ 1.5 billion in 2022 and US$ 2.8 billion by 2032. According to FMI, the market for endoscopic retrograde cholangiopancreatography (ERCP) devices is anticipated to grow at a compound annual growth rate (CAGR) of 6.2% between …